Disease: Kidney segment

AKBA		Akebia Therapeutics, Inc. - Common Stock			-5.08% up -8.54% 3.46		+ Medicine, Disease: Kidney Last highlighted: #AKBA SEC report: Akebia Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)] SEC Filing Form 10-Q filed by Akebia Therapeutics, Inc. -- SEC File Number 211148438	+ My List
CARA		Cara Therapeutics, Inc. - Common Stock			4.52% down 7.25% -2.73		+ Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat	+ My List
DMAC		DiaMedica Therapeutics Inc. - Common Stock			-1.36% up -7.91% 6.55		+ Biopharma, Disease: Kidney, Medicine, Disease: Acute ischemic stroke (AIS)	+ My List
RETA		Reata Pharmaceuticals, Inc. - Class A Common Stock			-4.9% up -8.35% 3.45		+ Pharmaceutical , Disease: Kidney, Medicine	+ My List
RNLX		Renalytix AI plc - American Depositary Shares			2.53% 2.53% 0		+ Country: Greate Britain, Medicine, Disease: Kidney, Artificial Intelligence Last highlighted: $RNLX 6-K Renalytix AI (2 Mar, 6:10am) 📰 RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 https://t.co/XIBCrGVTeh #RNLX #6K #RenalytixAI #News	+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.